{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:42:45Z","timestamp":1740148965093,"version":"3.37.3"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:00:00Z","timestamp":1715817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:00:00Z","timestamp":1715817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100012112","name":"Swedish Orphan Biovitrum","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012112","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s12325-024-02872-3","type":"journal-article","created":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T09:05:17Z","timestamp":1715850317000},"page":"2791-2807","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["florio\u00ae HAEMO: A Longitudinal Survey of Patient Preference, Adherence and Wearable Functionality in Central Europe"],"prefix":"10.1007","volume":"41","author":[{"given":"Ester","family":"Zapotocka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelika","family":"Batorova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernest","family":"Bilic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Boban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen Escuriola","family":"Ettingshausen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara Faganel","family":"Kotnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radomira","family":"Hrdlickova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawel","family":"Laguna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"M\u00e1chal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laszlo","family":"Nemes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irena Preloznik","family":"Zupan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gediminas","family":"Puras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianna","family":"Zombori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,16]]},"reference":[{"issue":"1","key":"2872_CR1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12929-021-00760-4","volume":"28","author":"D Okaygoun","year":"2021","unstructured":"Okaygoun D, et al. Advances in the management of haemophilia: emerging treatments and their mechanisms. J Biomed Sci. 2021;28(1):64.","journal-title":"J Biomed Sci"},{"issue":"2","key":"2872_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12685","volume":"6","author":"E Zapotocka","year":"2022","unstructured":"Zapotocka E, et al. First experience of a hemophilia monitoring platform: florio HAEMO. Res Pract Thromb Haemost. 2022;6(2): e12685.","journal-title":"Res Pract Thromb Haemost"},{"issue":"5","key":"2872_CR3","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1111\/hae.13287","volume":"23","author":"CRM Hay","year":"2017","unstructured":"Hay CRM, et al. The haemtrack home therapy reporting system: design, implementation, strengths and weaknesses: a report from UK Haemophilia Centre Doctors Organisation. Haemophilia. 2017;23(5):728\u201335.","journal-title":"Haemophilia"},{"issue":"4","key":"2872_CR4","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1055\/s-0038-1675575","volume":"39","author":"W Mondorf","year":"2019","unstructured":"Mondorf W, et al. Smart Medication \u2122, an electronic diary for surveillance of haemophilia home care and optimization of resource distribution. Hamostaseologie. 2019;39(4):339\u201346.","journal-title":"Hamostaseologie"},{"issue":"3","key":"2872_CR5","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/hae.14295","volume":"27","author":"A Arvanitakis","year":"2021","unstructured":"Arvanitakis A, et al. A comparison of MyPKFiT and WAPPS-Hemo as dosing tools for optimizing prophylaxis in patients with severe haemophilia A treated with Octocog alfa. Haemophilia. 2021;27(3):417\u201324.","journal-title":"Haemophilia"},{"key":"2872_CR6","unstructured":"McMaster University. WAPPS-Hemo. https:\/\/www.wapps-hemo.org\/. Published 2021. Accessed Dec 2023."},{"issue":"1","key":"2872_CR7","doi-asserted-by":"publisher","DOI":"10.2196\/34384","volume":"10","author":"S Huhn","year":"2022","unstructured":"Huhn S, et al. The impact of wearable technologies in health research: scoping review. JMIR Mhealth Uhealth. 2022;10(1): e34384.","journal-title":"JMIR Mhealth Uhealth"},{"issue":"3","key":"2872_CR8","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1111\/hae.14790","volume":"29","author":"C Dodd","year":"2023","unstructured":"Dodd C, et al. Wearable activity trackers in young people with haemophilia: what needs to be considered? Haemophilia. 2023;29(3):942\u20135.","journal-title":"Haemophilia"},{"issue":"7","key":"2872_CR9","doi-asserted-by":"publisher","DOI":"10.2196\/35684","volume":"10","author":"HS Kang","year":"2022","unstructured":"Kang HS, et al. Wearing the future-wearables to empower users to take greater responsibility for their health and care: scoping review. JMIR Mhealth Uhealth. 2022;10(7): e35684.","journal-title":"JMIR Mhealth Uhealth"},{"issue":"5","key":"2872_CR10","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1111\/hex.12083","volume":"18","author":"K Khair","year":"2015","unstructured":"Khair K, et al. Self-management and skills acquisition in boys with haemophilia. Health Expect. 2015;18(5):1105\u201313.","journal-title":"Health Expect"},{"key":"2872_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.711973","volume":"8","author":"N Dirzu","year":"2021","unstructured":"Dirzu N, et al. Mobile health technology for the personalized therapy of hemophilia. Front Med (Lausanne). 2021;8: 711973.","journal-title":"Front Med (Lausanne)"},{"key":"2872_CR12","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.2147\/PPA.S139851","volume":"11","author":"CD Thornburg","year":"2017","unstructured":"Thornburg CD, et al. Treatment adherence in hemophilia. Patient Prefer Adherence. 2017;11:1677\u201386.","journal-title":"Patient Prefer Adherence"},{"issue":"2","key":"2872_CR13","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/ejp.1313","volume":"23","author":"K Boric","year":"2019","unstructured":"Boric K, et al. Outcome domains and pain outcome measures in randomized controlled trials of interventions for postoperative pain in children and adolescents. Eur J Pain. 2019;23(2):389\u201396.","journal-title":"Eur J Pain"},{"issue":"7","key":"2872_CR14","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1097\/AJP.0000000000000574","volume":"34","author":"S Dosenovic","year":"2018","unstructured":"Dosenovic S, et al. Efficacy and safety outcome domains and outcome measures in systematic reviews of neuropathic pain conditions. Clin J Pain. 2018;34(7):674\u201384.","journal-title":"Clin J Pain"},{"issue":"5","key":"2872_CR15","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1097\/ACO.0000000000000780","volume":"32","author":"E Pogatzki-Zahn","year":"2019","unstructured":"Pogatzki-Zahn E, et al. Patient-reported outcome measures for acute and chronic pain: current knowledge and future directions. Curr Opin Anaesthesiol. 2019;32(5):616\u201322.","journal-title":"Curr Opin Anaesthesiol"},{"issue":"1","key":"2872_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000515576","volume":"5","author":"A Leroux","year":"2021","unstructured":"Leroux A, et al. Wearable devices: Current status and opportunities in pain assessment and management. Digit Biomark. 2021;5(1):89\u2013102.","journal-title":"Digit Biomark"},{"issue":"16","key":"2872_CR17","doi-asserted-by":"publisher","first-page":"5589","DOI":"10.3390\/s21165589","volume":"21","author":"V Vijayan","year":"2021","unstructured":"Vijayan V, et al. Review of wearable devices and data collection considerations for connected health. Sensors (Basel). 2021;21(16):5589.","journal-title":"Sensors (Basel)"},{"issue":"3","key":"2872_CR18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.15420\/ecr.2019.02","volume":"14","author":"MR Massoomi","year":"2019","unstructured":"Massoomi MR, et al. Increasing and evolving role of smart devices in modern medicine. Eur Cardiol. 2019;14(3):181\u20136.","journal-title":"Eur Cardiol"},{"key":"2872_CR19","doi-asserted-by":"publisher","first-page":"813","DOI":"10.2147\/PPA.S145647","volume":"12","author":"EC Morrissey","year":"2018","unstructured":"Morrissey EC, et al. Smartphone apps for improving medication adherence in hypertension: patients\u2019 perspectives. Patient Prefer Adherence. 2018;12:813\u201322.","journal-title":"Patient Prefer Adherence"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-024-02872-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-024-02872-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-024-02872-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T10:30:08Z","timestamp":1719570608000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-024-02872-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,16]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["2872"],"URL":"https:\/\/doi.org\/10.1007\/s12325-024-02872-3","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"type":"print","value":"0741-238X"},{"type":"electronic","value":"1865-8652"}],"subject":[],"published":{"date-parts":[[2024,5,16]]},"assertion":[{"value":"26 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Angelika Batorova received honoraria for consultancy and\/or speaker fees and\/or research funding from Grifols, Novo Nordisk, Octapharma, Pfizer, Sobi, and Takeda. Ana Boban received honoraria as an advisory board member and\/or speaker fees from Amgen, AstraZeneca, Bayer, CSL Behring, Novo Nordisk, Octapharma, Pfizer, Roche, Sobi, Swixx, and Takeda. Barbara Faganel Kotnik received honoraria for consultancy and\/or speaker fees from Bayer, Licentis, Roche, Pfizer, Sobi, and Takeda. Ernest Bilic received honoraria for consultancy and\/or speaker fees from Bayer, Octapharma, Novo Nordisk, Pfizer, Roche, and Sobi. Ester Zapotocka received honoraria for consultancy and\/or speaker fees from Novo Nordisk, Pfizer, Roche, Sobi, and Takeda. Carmen Escuriola Ettingshausen received honoraria for consultancy and\/or speakers fees from Bayer, Biomarin, CSL Behring, Florio HAEMO GmbH, Grifols, Kedrion, LFB, Octapharma, Roche\/Chugai, Novo Nordisk, Pfizer, Sobi, and Shire\/Takeda. Gediminas Puras is a current employee of Sobi. Radomira Hrdlickova received honoraria for consultancy and\/or speaker fees from Bayer, Novo Nordisk, Octapharma, Pfizer, Roche, Sobi, and Takeda. Laszlo Nemes received honoraria for consultancy and\/or speaker fees from Novo Nordisk, Sobi, Takeda, Roche, CSL Behring, and Bayer. Marianna Zombori received honoraria for consultancy and\/or speaker fees from Bayer, CSL Behring, Octapharma, Novo Nordisk, Pfizer, Takeda, Octapharma, Kedrion, Novartis, Biotest, Sobi, and Roche. Pawel Laguna participated in clinical trials and received remuneration for lectures and consultations from Baxter, Takeda, Bayer Schering Pharma, CSL Behring, Biogen, Grifols, Novo Nordisk, Octapharma, Sobi, and Roche. Irena Preloznik Zupan and Jan Machal report no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study was conducted in compliance with European General Data Protection Regulation 2016\/679, local legislation and Ethics Committee approval (University Hospital Bratislava Ethics Committee) in accordance with the Helsinki Declaration of 1964 and its later amendments. All participants provided informed consent for partaking in the study and any subsequent publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}